Gene therapy by membrane-expressed superantigen for α-fetoprotein-producing hepatocellular carcinoma

Gene Therapy

Volumn 13, Issue 22, 2006, Pages 1603-1610

  Si, S ^a   Sun, Y ^a   Li, Z ^a   Ge, W ^a   Zhang, X ^a   Hu, P ^a   Huang, Y ^a,a   Chen, G ^a   Song, H ^a   Ma, B ^a   Li, X ^a   Sui, Y ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; B7 ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN;

ADENOVIRUS VECTOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENHANCER REGION; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROMOTER REGION; SPLEEN CELL; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INFECTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ALPHA-FETOPROTEINS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MEMBRANE; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENTEROTOXINS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; STAPHYLOCOCCUS;

EID: 33750617460     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302823     Document Type: Article

References (36)

1. Melief CJ. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 1992; 58: 143-175.
2. Baskar S. Gene-modified tumor cells as cellular vaccine. Cancer Immunol Immunother 1996; 43: 165-173.
3. Putzer BM, Stiewe T, Rodicker F, Schildgen O, Ruhm S, Dirsch O et al. Large nontransplanted hepatocellular carcinoma in woodchucks: Treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes. J Natl Cancer Inst 2001; 93: 472-479.
4. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8: 411-426.
5. Dohlsten M, Lando PA, Hedlund G, Trowsdale J, Kalland T. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins. Immunology 1990; 71: 96-100.
6. Dohlsten M, Sundstedt A, Bjorklund M, Hedlund G, Kalland T. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 1993; 54: 482-488.
7. Li ZS, Yang XW, Chen Z, Dong HL, Ye J, Qu P et al. In vivo tumor co-transfection with superantigen and CD80 induces systemic immunity without tolerance and prolongs survival in mice with hepatocellular carcinoma. Cancer Biol Ther 2004; 9: 660-666.
8. Nielsen SE, Zeuthen J, Lund B, Persson B, Alenfall J, Hansen HH. Phase I study of single, escalating doses of a superantigen- antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma. J Immunother 2000; 23: 146-153.
9. Cheng JD, Babb JS, Langer C, Aamdal S, Robert F, Engelhardt LR et al. Individualized patient dosing in phase I clinical trials: The role of escalation with overdose control in PNU-214936. J Clin Oncol 2004; 22: 602-609.
10. Wahlsten JL, Mills CD, Ramakrishnan S. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells. J Immunol 1998; 161: 6761-6767.
11. Litton MJ, Dohlsten M, Hansson J, Rosendahl A, Ohlsson L, Kalland T et al. Tumor therapy with an antibody-targeted superantigen generation a dichotomy between local and systemic immune responses. Am J Pathol 1997; 150: 1607-1618.
12. Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Wang WY. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma. World J Gastroenterol 2003; 9: 688-691.
13. Nakaya H, Ishizu A, Ikeda H, Tahara M, Shindo J, Itoh R et al. In vitro model of suicide gene therapy for alpha-fetoprotein- producing gastric cancer. Anticancer Res 2003; 23: 3795-3800.
14. Song JS. Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer. Biosci Biotechnol Biochem 2005; 69: 56-62.
15. Spear BT. Alpha-fetoprotein gene regulation: Lessons from transgenic mice. Semin Cancer Bio 1999; 19: 109-116.
16. Kawabata K, Sakurai F, Yamaguchi T, Hayakawa T, Mizuguchi H. Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Mol Ther 2005; 12: 547-554.
17. Miller WH, Brosnan MJ, Graham D, Nicol CG, Morecroft I, Channon KM et al. Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats. Mol Ther 2005; 12: 321-327.
18. Green JM, Turka LA, June CH, Thompson CB. CD28 and staphylococcal enterotoxins synergize to induce MHC-independent T-cell proliferation. Cell Immunol 1992; 145: 11-20.
19. Taub D, Rogers TJ. Direct activation of murine T cells by staphylococcal enterotoxins. Cell Immunol 1992; 140: 267-281.
20. Ihle J, Holzer U, Krull F, Dohlsten M, Kalland T, Niethammer D et al. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell lines. Cancer Res 1995; 55: 623-628.
21. Holzer U, Bethge W, Krull F, Ihle J, Handgretinger R, Reisfeld RA et al. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells. Cancer Immunol Immunother 1995; 41: 129-136.
22. Dighe AS, Richards E, Old LJ, Schreiber RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN-γreceptors. Immunity 1994; 1: 447.
23. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ et al. Demonstration of an interferon-γ-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998; 95: 7556.
24. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old J et al. IFN-γand lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410: 1107.
25. Street SE, Cretney E, Smyth MJ. Perforin and interferon- γactivities independently control tumor initiation, growth, and metastasis. Blood 2001; 97: 192.
26. Street SE, Trapani JA, MacGregor D, Smyth MJ. Suppression of lymphoma and epithelial malignancies effected by interferon-γ. J Exp Med 2002; 196: 129.
27. Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M et al. The critical role of Th1-dominant immunity in tumorimmunology. Cancer Chemother Pharmacol 2000; 46: S52.
28. Rosendahl A, Kristensson K, Hansson J, Riesbeck K, Kalland T, Dohlsten M. Perforin and IFN-γ are involved in the antitumor effects of antibody-targeted superantigens. J Immunol 1998; 160: 5309.
29. Melief CJ, Kast WM. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol Rev 1995; 45: 167.
30. Sogaard M, Hansson J, Litton MJ, Ohlsson L, Rosendahl A, Lando PA et al. Antibody-targeted superantigens in cancer immunotherapy. Immunotechnology 1996; 2: 151-162.
31. Dohlsten M, Sundstedt A, Björklund M, Hedlund G, Kalland T. Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 1993; 54: 482-488.
32. Dohlsten M, Hedlund G, Akerblom E, Lando PA, Kalland T. Monoclonal antibody-targeted superantigens: A different class of anti-tumor agents. Proc Natl Acad Sci USA 1991; 88: 9287-9291.
33. Lando PA, Dohlsten M, Hedlund G, Akerblom E, Kalland T. T cell killing of human colon carcinomas by monoclonal- antibody targeted superantigens. Cancer Immunol Immunother 1993; 36: 223-228.
34. Lando PA, Hedlund G, Dohlsten M, Kalland T. Bacterial superantigens as anti-tumor agents: Induction of tumor cytotoxicity in human lymphocytes by staphylococcal enterotoxin A. Cancer Immunol Immunother 1991; 3: 231-237.
35. Dohlsten M, Lando PA, Bjork P, Abrahmsen L, Ohlsson L, Lind P et al. Immunotherapy of human colon cancer by antibody- targeted superantigens. Cancer Immunol Immunother 1995; 41: 162-168.
36. Nakabeppu Y, Oda S, Sekiguchi M. Proliferative activation of quiescent Rat-1 A cells by delta FosB. Mol Cell Biol 1993; 13: 4157-4166.